This study aims to investigate whether inducing transdifferentiation in pancreatic cancer cells can reduce malignancy, focusing on the role of the transcription factor NeuroD1 and its regulatory pathways. This evidence concerns the gene NEUROD1 and pancreatic neoplasm.